타가토스 시장 규모 : 유형별, 용도별, 유통 채널별 - 예측(2024-2032년)

Global Tagatose Market will infer over 4.7% CAGR between 2024 and 2032, driven by escalating health consciousness. Rising awareness of health benefits and the demand for low-calorie sweeteners are key catalysts of the market. This natural sweetener, known for its low caloric content and prebiotic properties, is increasingly used in the food and beverage industry. The ever-growing burden of diabetes is propelling the demand for tagatose during the forecast period. As per the IDF Diabetes Atlas, 10.5% of adults (20-79 years) have diabetes, with nearly half unaware of their condition. By 2045, projections indicate that 1 in 8 adults, or about 783 million, will have diabetes, a 46% increase.

Diabetic people require low glycemic index alternatives and find Tagatose suitable for consumption. Technological advancements in production have also made Tagatose more cost-effective, while consumer preference for natural ingredients and the rise of functional foods have opened new market avenues. These factors collectively strengthen the growth of the tagatose market.

The overall tagatose industry is sorted based on type, application, distribution channel, and region.

The pharmaceuticals segment will clutch a significant tagatose market share by 2032 because of its potential therapeutic benefits. Its prebiotic properties enhance gut health, supporting its use in digestive health supplements. Additionally, Tagatose shows promise in managing hyperglycemia and metabolic disorders, making it valuable for diabetes-related treatments. Its low glycemic index and minimal impact on blood sugar levels make it a safe ingredient in medications for diabetic patients. Ongoing research into Tagatose's antioxidant and anti-inflammatory properties suggests its potential in broader pharmaceutical applications, ushering in its demand.

The L-Tagatose segment will exhibit a promising CAGR from 2024 to 2032, owing to its unique metabolic pathway, which allows it to be minimally absorbed by the body, resulting in lower blood sugar levels. This characteristic makes it highly desirable for weight management and obesity prevention. Additionally, L-Tagatose's natural occurrence in dairy products and fruits appeals to consumers seeking authentic, less processed ingredients. Due to its non-cariogenic nature, its application in dental health products boosts its demand as consumers increasingly prioritize oral health and overall well-being.

Europe tagatose market thrives with a noteworthy CGAR through 2032 due to the increasing focus on sustainable and natural ingredients. European consumers are becoming more health-conscious, leading to a higher preference for low-calorie and low-glycemic sweeteners like Tagatose. Additionally, stringent regulations on artificial sweeteners and a strong push towards clean-label products proliferate manufacturers to opt for natural alternatives. The escalating market for functional foods and beverages in Europe contributes to the demand, as Tagatose aligns with trends for health-enhancing ingredients.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Data Mining sources
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Type trends
• 2.3 Application trends
• 2.4 Distribution channel trends

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Value chain
  • 3.1.2 Key manufacturers
  • 3.1.3 Go to market routes
  • 3.1.4 Key distributors
    • 3.1.4.1 New distribution channels
  • 3.1.5 Profit margins across the industry
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Demand for natural ingredients
    • 3.2.1.2 Increasing health consciousness
    • 3.2.1.3 Product innovation and diversification
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1. Competition from existing sweeteners
    • 3.2.2.2. High production cost
  • 3.2.3 Market opportunities
    • 3.2.3.1 New markets/applications
    • 3.2.3.2 Growth potential analysis
• 3.3 Raw material landscape
  • 3.3.1 Manufacturing trends
    • 3.3.1.1 Technology evolution
    • 3.3.1.2 Sustainable manufacturing
      • 3.3.1.2.1 Green practices
      • 3.3.1.2.2 Decarbonization
  • 3.3.2 New raw materials
  • 3.3.3 Raw material pricing trends (USD/Ton)
    • 3.3.3.1 U.S.
    • 3.3.3.2 European Union
    • 3.3.3.3 UK
    • 3.3.3.4 China
    • 3.3.3.5 Southeast Asia
    • 3.3.3.6 GCC
• 3.4 Regulations & market impact
• 3.5 Trade statistics
• 3.6 Unmet needs
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Type, 2021-2032 (USD Million, Kilo Tons)

• 5.1 Key trends
• 5.2 L-Tagatose
• 5.3 D-Tagatose

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

• 6.1 Key trends
• 6.2 Food and beverage
• 6.3 Pharmaceutical
• 6.4 Personal care
• 6.5 Animal feed
• 6.6 Other

Chapter 7 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

• 7.1 Key trends
• 7.2 Online retail
• 7.3 Specialty store
• 7.4 Direct sale

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 MEA
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa
  • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Alfa chemistry
• 9.2 Bio sugar technology
• 9.3 BLD pharm
• 9.4 Bonumose LLC
• 9.5 Chemily glycosciece
• 9.6 Merck
• 9.7 Ottokemi pvt ltd
• 9.8 Santa cruz biotechnology
• 9.9 Spectrum chemical
• 9.10 Syngars
• 9.11 Tokyo Chemical Industry
• 9.12 Zhejiang yixin pharamceutical co ltd